In case you haven’t already, check out Biocept on our other social media platforms! #GetCancerAnswers
LinkedIn:
https://t.co/qeCkWkYQmu
Facebook:
https://t.co/MSD7wzvPjR
Instagram:
https://t.co/iDE02zWK5w
We’re simply having a wonderful festive thyme! Thanks to all those who made our space feel jolly during our holiday workplace decorating contest and congratulations to our winners! (Part 3)
We’re simply having a wonderful festive thyme! Thanks to all those who made our space feel jolly during our holiday workplace decorating contest and congratulations to our winners! (Part 2)
We’re simply having a wonderful festive thyme! Thanks to all those who made our space feel jolly during our holiday workplace decorating contest and congratulations to our winners! (Part 1)
“When you’re diagnosed with a brain tumor, it’s not just a chapter in your life.” – Dan Zappa
Together, let’s continue to invest in hope for patients with LM and brain tumors. Visit https://t.co/g12YpfLytr to donate this holiday season.
@theABTA#GetCancerAnswers
Today is #GivingTuesday. Together, let’s invest in hope for patients with leptomeningeal metastasis and brain tumors.
In the spirit of holiday giving, donate now to @theABTA: https://t.co/EBVEG4XgZj
#GetCancerAnswers
Visit Biocept’s booth (#512) at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology and learn about the clinical poster on mutant p53 positive glioblastoma cells being presented on Friday, 11/18 from 7:30-9:30 PM ET. #CNSide#GetCancerAnswers#SNO2022
Visit Biocept’s booth (#512) at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology and learn about the PPTID clinical poster being presented on Friday, 11/18 from 7:30-9:30 PM ET. @NeuroOnc#CNSide#GetCancerAnswers#SNO2022
Visit Biocept’s booth (#512) at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology and learn about the HER2 Flip clinical poster being presented on Friday, 11/18 from 7:30-9:30 PM ET. @NeuroOnc#GetCancerAnswers#SNO2022
#InTheNews: Biocept Expands Commercial Offering of CNSide™ Assay to Most Cancers that Metastasize to the Central Nervous System
Learn more: https://t.co/3GfZQHcixA
#CNSide#GetCancerAnswers
Join our CNSide webinar on October 14th at 1:00pm ET, featuring key opinion leaders Priya U. Kumthekar, MD and Seema A. Nagpal, MD.
Register here: https://t.co/Umx8YAAmGI
#CNSide#GetCancerAnswers
Did you know? Biocept initiated a clinical trial, the FORESEE Study, for patients with breast or non-small cell lung cancer (NSCLC) who have suspected or confirmed leptomeningeal metastases (LM).
Learn more: https://t.co/WJm68JyKre
#CNSide#GetCancerAnswers#FORESEEStudy
@theABTA is hosting a free, virtual meeting for brain tumor patients, caregivers, families, and survivors on September 9-10th. Leading experts in the field will share the latest advances. The final day to register is September 7th.
Learn more here: https://t.co/z4x5JTJ5LA
#IntheNews: Plus Therapeutics Awarded $17.6 Million from State of Texas. The funding will support the ReSPECT-LM Study and development of Rhenium-186 NanoLiposome (186RNL) for leptomeningeal metastases. Learn more on @plustxinc:
https://t.co/iphCxfhYUI
#ClinicalTrial#CNSide